Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Capital Employed: 2018-2025

Historic Return on Capital Employed for Puma Biotechnology (PBYI) over the last 8 years, with Sep 2025 value amounting to 0.29%.

  • Puma Biotechnology's Return on Capital Employed fell 3.00% to 0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of 0.25% for FY2024, which is 1.00% down from last year.
  • Latest data reveals that Puma Biotechnology reported Return on Capital Employed of 0.29% as of Q3 2025, which was down 26.97% from 0.40% recorded in Q2 2025.
  • In the past 5 years, Puma Biotechnology's Return on Capital Employed ranged from a high of 0.40% in Q2 2025 and a low of -0.19% during Q1 2022.
  • For the 3-year period, Puma Biotechnology's Return on Capital Employed averaged around 0.25%, with its median value being 0.26% (2024).
  • As far as peak fluctuations go, Puma Biotechnology's Return on Capital Employed skyrocketed by 49bps in 2021, and later decreased by 23bps in 2022.
  • Puma Biotechnology's Return on Capital Employed (Quarterly) stood at -0.05% in 2021, then rose by 23bps to 0.18% in 2022, then climbed by 10bps to 0.28% in 2023, then fell by 2bps to 0.26% in 2024, then declined by 3bps to 0.29% in 2025.
  • Its Return on Capital Employed was 0.29% in Q3 2025, compared to 0.40% in Q2 2025 and 0.32% in Q1 2025.